Compound Profiling & Screening Services
Get robust compound data in human tissue models
We generate robust compound response data in established MIMETAS tissue models. By deploying our validated phenotypic assays within standardized screening workflows, we offer compound profiling services to support preclinical development programs.
Safety profiling & screening
De-risking early development programs by leveraging our expertise in detecting adverse compound effects in therapeutically-relevant healthy tissue models and readouts.
Drug delivery & transport assessment
Monitoring drug transport across novel healthy barrier tissue models, for candidate selection and delivery optimization.
For more information on our compound profiling and screening services, please get in touch with us.